The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia

Clinica Chimica Acta

Volumn 263, Issue 1, 1997, Pages 67-77

  Human, Johanna A ^a   Ubbink, Johan B ^a   Jerling, Johann J ^b   Delport, Rhena ^a   Vermaak, W J Hayward ^a   Vorster, Hester H ^b   Lagendijk, Jennifer ^a   Potgieter, Hendrik C ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Coenzyme Q10; Familial hypercholesterolaemia; HMG CoA reductase inhibitor; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; UBIDECARENONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; LIPID PEROXIDATION; LOVASTATIN; MALE; MIDDLE AGED; SIMVASTATIN; UBIQUINONE; VITAMIN E;

EID: 0030838365     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)06557-1     Document Type: Article

References (39)

1. Havel RJ, Hunninghake DB, Illingworth DR et al. Lovastatin (Mevinolin) in the treatment of heterozygous familial hypercholesterolaemia: a multicentre study. Ann Intern Med 1987;107:609-15.
2. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta 1983;737:197-222.
3. Levy RI. Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospects. Clin Chem 1981;27:653-62.
4. Farinaro E, Stein Y, Assmann G et al. Prevention of coronary heart disease: scientific bases of prevention. In: Assmann G ed. Lipid metabolism disorders and coronary heart disease: Primary prevention, diagnosis and therapy guidelines for general practice. MMV Medizin Verlag, 1993:71-85.
5. Grundy SM. Cholesterol and coronary heart disease: a new era. J Am Med Assoc 1986;256:2849-58.
6. Rossouw JE, Steyn K, Berger GMB et al. Action limits for serum total cholesterol. South Afr Med J 1988;73:693-700.
7. Abbey M, Nestel PJ, Baghurst PA. Antioxidant vitamins and low-density-lipoprotein oxidation. Am J Clin Nutr 1993;58:525-32.
8. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993;71:9B-14B.
9. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol Med 1992;13:341-90.
10. Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
11. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with alpha-tocopherol but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992;12:554-62.
12. Tribble DL, van den Berg JJM, Motchnik PA et al. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content. Proc Natl Acad Sci USA 1994;91:1183-7.
13. Harats D, Ben-Naim M, Dabach Y et al. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47-54.
14. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. Biochim Biophys Acta 1995;1258:177-87.
15. Doba T, Burton GW, Ingold KU. Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of alpha-tocopherol or a water-soluble alpha-tocopherol analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta 1985;835:298-303.
16. Retsky KL, Frei B. Vitamin C prevents metal ion-dependant initiation and propagation of lipid peroxidation in human low density lipoprotein. Biochim Biophys Acta 1995;1257:279-87.
17. Frei B, England L, Ames BW. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81.
18. The International Taskforce for the Prevention of coronary heart disease. Guidelines of the European Atherosclerosis Society. Nutrition, metabolism and cardiovascular diseases 1992;2:113-56.
19. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
20. Stephans NG, Parsons A, Schofield PM et al. Randomised controlled trial of alphatocopherol in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 1996;347:781-6.
21. Rapola JM, Virtamo J, Haukka JK et al. Effect of alpha-tocopherol and beta-carotene on the incidence of angina pectoris. J Am Med Assoc 1996;275:693-8.
22. Hodis HN, Mack WJ, LaBree L et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. J Am Med Assoc 1995;273:1849-54.
23. Folkers K, Langsjoen P, Willis R et al. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 1990;87:8931-4.
24. Watts GF, Castelluccio C, Rice-Evans C, Taub NA, Baum H, Quinn PJ. Plasma coenzyme Q (ubiquinone) concentrations in patients treated with Simvastatin. J Clin Pathol 1993;46:1055-7.
25. Hoffman R, Brock GJ, Aviram M. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis 1992;93:105-13.
26. Salonen R, Nyyssönen K, Parkkala-Sarataho E, Salonen JT. The Kupio Atherosclerosis Prevention Study (KAPS): effect of Pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Am J Cardiol 1995;76:34-9C.
27. Raal FJ, Areias AJ, Waisberg R, Van Arb M. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia. Atherosclerosis 1995;115:9-15.
28. Catignani GL. An HPLC-method for the simultaneous determination of retinol and α-tocopherol in plasma or serum. Methods Enzymol 1986;123:215-9.
29. Robinson CH, Lawler MR, Chenoweth WL, Garwick AE. The fat-soluble vitamins. In: Robinson CH, Lawler MR, eds. Normal and therapeutic nutrition. New York: Macmillan Publishing Company, 1986:156-71.
30. Mahan LK, Arlin M. Vitamins. In: Mahan LK, Arlin M eds. Krause's food, nutrition and diet therapy. Philadelphia: WB Saunders, 1992:71-108.
31. Milne DB, Botnen J. Retinol, α-tocopherol, lycopene and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874-6.
32. Liau LS, Lee BL, New AL, Ong CN. Determination of plasma ascorbic acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr 1993;612:63-70.
33. 10 in human plasma as a possible marker of oxidative stress. J Lipid Res 1996;37:67-75.
34. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of an in vitro oxidation of human low density lipoprotein. Free Radical Res Commun 1989;6:67-75.
35. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-50.
36. Rifici VA, Kachadurian AK. Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. J Am Coll Nutr 1993;12:631-7.
37. Beuttner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol and ascorbate. Arch. Biochem Biophys 1993;300:535-43.
38. Freyschuss A, Stiko-Rahm A, Swedenborg J et al. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterlaemic rabbits. J Clin Invest 1993;91:1282-8.
39. Sasahara M, Raines EW, Chait A et al. Inhibition of hypercholesterolaemia-induced atherosclerosis in the nonhuman primate by Probucol. J Clin Invest 1994;94:155-64.